Featured GeneDx blog posts

The Stargardt disease treatment landscape is changing rapidly. Learn how genetically characterized ABCA4 data within GeneDx Infinity™ is helping researchers identify patients, strengthen clinical trials, and accelerate the development of new therapies.

GeneDx has redesigned its exome and genome test reports to make results easier to find, understand, and discuss. See how the new format improves the experience while preserving the same trusted scientific interpretation.

One year after the American Academy of Pediatrics updated its recommendations for genetic evaluation in children with unexplained global developmental delay and intellectual disability, the impact continues to shape pediatric care. Explore how the report helped accelerate earlier diagnosis, improve access to genomic medicine, and support a growing era of precision care.